Sarah Spencer

Sarah Spencer is Principal at EcoR1 Capital, LLC in San Francisco, where she leads due diligence and analysis for value-oriented investments in biotechnology companies. Her responsibilities include identifying promising biotech firms and evaluating their scientific, financial, and strategic prospects within the life sciences sector, with a particular focus on therapeutics and drug development.

Prior to her current role, Sarah was an Analyst at EcoR1 Capital and began her investment career at the University of Virginia Investment Management Company (UVIMCO), where she conducted diligence on investment managers across various asset classes. Her track record demonstrates a strong background in finance and investment analysis within alternative asset management, especially in biotech equities and venture capital.

Sarah holds a Bachelor of Arts in Economics with a minor in History from the University of Virginia. She is recognized for her expertise in biotechnology sector analysis and is a member of the Board of Advisors for Life Science Cares Bay Area, contributing to both investment innovation and community impact in the life sciences industry.